Unveiling Therapeutic Targets for Esophageal Cancer: A Comprehensive Review
Current Oncology · 2023
DOI: 10.3390/curroncol30110691 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Oncology, 2023. Verfasst von Rakesh Acharya und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Zoology, Guru Ghasidas Vishwavidyalaya, Bilaspur 495009, India. Hauptthemen laut MEDLINE: Esophageal Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Esophageal cancer is a highly aggressive and deadly disease, ranking as the sixth leading cause of cancer-related deaths worldwide. Despite advances in treatment, the prognosis remains poor. A multidisciplinary approach is crucial for achieving complete remission, with treatment options varying based on disease stage. Surgical intervention and endoscopic treatment are used for localized cancer, while systemic treatments like chemoradiotherapy and targeted drug therapy play a crucial role. Molecular markers such as HER2 and EGFR can be targeted with drugs like trastuzumab and cetuximab, and immunotherapy drugs like pembrolizumab and nivolumab show promise by targeting immune checkpoint proteins. Epigenetic modifications offer new avenues for targeted therapy. Treatment selection depends on factors like stage, tumor location, and patient health, with post-operative and rehabilitation care being essential. Early diagnosis, appropriate treatment, and supportive care are key to improving outcomes. Continued research is needed to develop effective targeted drugs with minimal side effects. This review serves as a valuable resource for clinicians and researchers dedicated to enhancing esophageal cancer treatment outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Zoology, Guru Ghasidas Vishwavidyalaya, Bilaspur 495009, India.
- Department of Immunopathology, Institute of lungs Health and Immunity, Comprehensive Pneumology Center, Helmholtz Zentrum, Neuherberg, 85764 Munich, Germany.
ORCID-Profile: Rakesh Acharya, Ananya Mahapatra, Henu Kumar Verma, L V K S Bhaskar
Zitieren
APA
Acharya, R., Mahapatra, A., Verma, H. K., & Bhaskar, L. V. K. S. (2023). Unveiling Therapeutic Targets for Esophageal Cancer: A Comprehensive Review. Current Oncology. https://doi.org/10.3390/curroncol30110691
Vancouver
Acharya R, Mahapatra A, Verma HK, Bhaskar LVKS. Unveiling Therapeutic Targets for Esophageal Cancer: A Comprehensive Review. Current Oncology. 2023. doi:10.3390/curroncol30110691
BibTeX
@article{Acharya2023,
author = {Acharya, Rakesh and Mahapatra, Ananya and Verma, Henu Kumar and Bhaskar, L V K S},
title = {Unveiling Therapeutic Targets for Esophageal Cancer: A Comprehensive Review},
journal = {Current Oncology},
year = {2023},
doi = {10.3390/curroncol30110691}
}
EUVIMED